Skip to main content
Advanced Technical IVT

oncogene addiction

A cancer cell's dependence on continued oncogene activity for survival and proliferation, creating therapeutic vulnerability when the oncogene is targeted.

Full Definition

Oncogene addiction describes the phenomenon where cancer cells become dependent on the continued function of specific oncogenes for their survival, even when multiple genetic alterations are present. This concept is fundamental to precision oncology because it explains why targeting a single oncogene can be therapeutically effective despite tumor complexity. When cancer cells develop addiction to an oncogene like EGFR or HER2, targeted inhibition can lead to dramatic tumor responses. The principle underlies many successful precision oncology treatments, including imatinib for BCR-ABL1-positive leukemias and trastuzumab for HER2-positive breast cancers. Understanding oncogene addiction helps predict which patients will benefit from specific targeted therapies.

Usage

Usage note: Capitalize when referring to the formal concept; lowercase in general usage.

In Context

  • "The dramatic response to erlotinib demonstrated classic oncogene addiction to mutant EGFR." — case study report
  • "Oncogene addiction provides the rationale for single-agent targeted therapy in precision oncology." — review article

Also known as

oncogene dependence

Contrasted with

oncogene independence

Don't confuse with

driver mutation tumor suppressor loss

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON